Return to Statistics Toolbox

Volcano Plot analysis for Study ST004535

(Analysis All analyses used)
Select one or more experimental factors for Groups 1 and 2. The members of each group should be DIFFERENT.
Group1Experimental factorGroup2
Sample source:BT | Treatment:Control | Replicate:1 | Sample Type:Pellet (1)
Sample source:BT | Treatment:Control | Replicate:1 | Sample Type:Supernatant (1)
Sample source:BT | Treatment:Control | Replicate:2 | Sample Type:Pellet (1)
Sample source:BT | Treatment:Control | Replicate:2 | Sample Type:Supernatant (1)
Sample source:BT | Treatment:Control | Replicate:3 | Sample Type:Pellet (1)
Sample source:BT | Treatment:Control | Replicate:3 | Sample Type:Supernatant (1)
Sample source:BT | Treatment:Control | Replicate:4 | Sample Type:Pellet (1)
Sample source:BT | Treatment:Control | Replicate:4 | Sample Type:Supernatant (1)
Sample source:BT | Treatment:Control | Replicate:5 | Sample Type:Pellet (1)
Sample source:BT | Treatment:Control | Replicate:5 | Sample Type:Supernatant (1)
Sample source:BT | Treatment:final concentration 300µM DCA | Replicate:1 | Sample Type:Pellet (1)
Sample source:BT | Treatment:final concentration 300µM DCA | Replicate:1 | Sample Type:Supernatant (1)
Sample source:BT | Treatment:final concentration 300µM DCA | Replicate:2 | Sample Type:Pellet (1)
Sample source:BT | Treatment:final concentration 300µM DCA | Replicate:2 | Sample Type:Supernatant (1)
Sample source:BT | Treatment:final concentration 300µM DCA | Replicate:3 | Sample Type:Pellet (1)
Sample source:BT | Treatment:final concentration 300µM DCA | Replicate:3 | Sample Type:Supernatant (1)
Sample source:BT | Treatment:final concentration 300µM DCA | Replicate:4 | Sample Type:Pellet (1)
Sample source:BT | Treatment:final concentration 300µM DCA | Replicate:4 | Sample Type:Supernatant (1)
Sample source:BT | Treatment:final concentration 300µM DCA | Replicate:5 | Sample Type:Pellet (1)
Sample source:BT | Treatment:final concentration 300µM DCA | Replicate:5 | Sample Type:Supernatant (1)
Sample source:CA | Treatment:Control | Replicate:1 | Sample Type:Pellet (1)
Sample source:CA | Treatment:Control | Replicate:1 | Sample Type:Supernatant (1)
Sample source:CA | Treatment:Control | Replicate:2 | Sample Type:Pellet (1)
Sample source:CA | Treatment:Control | Replicate:2 | Sample Type:Supernatant (1)
Sample source:CA | Treatment:Control | Replicate:3 | Sample Type:Pellet (1)
Sample source:CA | Treatment:Control | Replicate:3 | Sample Type:Supernatant (1)
Sample source:CA | Treatment:Control | Replicate:4 | Sample Type:Pellet (1)
Sample source:CA | Treatment:Control | Replicate:4 | Sample Type:Supernatant (1)
Sample source:CA | Treatment:Control | Replicate:5 | Sample Type:Pellet (1)
Sample source:CA | Treatment:Control | Replicate:5 | Sample Type:Supernatant (1)
Sample source:CA | Treatment:final concentration 300µM DCA | Replicate:1 | Sample Type:Pellet (1)
Sample source:CA | Treatment:final concentration 300µM DCA | Replicate:1 | Sample Type:Supernatant (1)
Sample source:CA | Treatment:final concentration 300µM DCA | Replicate:2 | Sample Type:Pellet (1)
Sample source:CA | Treatment:final concentration 300µM DCA | Replicate:2 | Sample Type:Supernatant (1)
Sample source:CA | Treatment:final concentration 300µM DCA | Replicate:3 | Sample Type:Pellet (1)
Sample source:CA | Treatment:final concentration 300µM DCA | Replicate:3 | Sample Type:Supernatant (1)
Sample source:CA | Treatment:final concentration 300µM DCA | Replicate:4 | Sample Type:Pellet (1)
Sample source:CA | Treatment:final concentration 300µM DCA | Replicate:4 | Sample Type:Supernatant (1)
Sample source:CA | Treatment:final concentration 300µM DCA | Replicate:5 | Sample Type:Pellet (1)
Sample source:CA | Treatment:final concentration 300µM DCA | Replicate:5 | Sample Type:Supernatant (1)
Sample source:Co | Treatment:Control | Replicate:1 | Sample Type:Pellet (1)
Sample source:Co | Treatment:Control | Replicate:1 | Sample Type:Supernatant (1)
Sample source:Co | Treatment:Control | Replicate:2 | Sample Type:Pellet (1)
Sample source:Co | Treatment:Control | Replicate:2 | Sample Type:Supernatant (1)
Sample source:Co | Treatment:Control | Replicate:3 | Sample Type:Pellet (1)
Sample source:Co | Treatment:Control | Replicate:3 | Sample Type:Supernatant (1)
Sample source:Co | Treatment:Control | Replicate:4 | Sample Type:Pellet (1)
Sample source:Co | Treatment:Control | Replicate:4 | Sample Type:Supernatant (1)
Sample source:Co | Treatment:Control | Replicate:5 | Sample Type:Supernatant (1)
Sample source:Co | Treatment:final concentration 300µM DCA | Replicate:1 | Sample Type:Supernatant (1)
Sample source:Co | Treatment:final concentration 300µM DCA | Replicate:2 | Sample Type:Supernatant (1)
Sample source:Co | Treatment:final concentration 300µM DCA | Replicate:3 | Sample Type:Supernatant (1)
Sample source:Co | Treatment:final concentration 300µM DCA | Replicate:4 | Sample Type:Pellet (1)
Sample source:Co | Treatment:final concentration 300µM DCA | Replicate:4 | Sample Type:Supernatant (1)
Sample source:Co | Treatment:final concentration 300µM DCA | Replicate:5 | Sample Type:Pellet (1)
Sample source:Co | Treatment:final concentration 300µM DCA | Replicate:5 | Sample Type:Supernatant (1)
Sample source:NA | Treatment:Blank | Replicate:1 | Sample Type:Supernatant (2)
P-value cutoff:    Fold-change cutoff:    Sample normalization:
Group by metabolite classification:    Use:
Maximum # of (most significant) metabolites per class to use in pvalue group calculation:
Analysis:Combine data for all analyses?:     

  logo